Riverhead Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $986K | Sell |
3,556
-236
| -6% | -$65.4K | 0.04% | 492 |
|
|
2019
Q2 | $1.19M | Sell |
3,792
-2,555
| -40% | -$800K | 0.04% | 445 |
|
|
2019
Q1 | $2.61M | Buy |
6,347
+4,185
| +194% | +$1.72M | 0.11% | 260 |
|
|
2018
Q4 | $808K | Buy |
2,162
+412
| +24% | +$154K | 0.04% | 503 |
|
|
2018
Q3 | $707K | Buy |
1,750
+450
| +35% | +$182K | 0.03% | 603 |
|
|
2018
Q2 | $448K | Buy |
1,300
+80
| +7% | +$27.6K | 0.02% | 717 |
|
|
2018
Q1 | $420K | Sell |
1,220
-186
| -13% | -$64K | 0.02% | 727 |
|
|
2017
Q4 | $529K | Buy |
1,406
+650
| +86% | +$245K | 0.02% | 639 |
|
|
2017
Q3 | $338K | Hold |
756
| – | – | 0.02% | 751 |
|
|
2017
Q2 | $371K | Sell |
756
-129
| -15% | -$63.3K | 0.02% | 696 |
|
|
2017
Q1 | $343K | Buy |
885
+229
| +35% | +$88.8K | 0.02% | 628 |
|
|
2016
Q4 | $241K | Sell |
656
-100
| -13% | -$36.7K | 0.01% | 684 |
|
|
2016
Q3 | $304K | Sell |
756
-1,400
| -65% | -$563K | 0.02% | 588 |
|
|
2016
Q2 | $119K | Sell |
2,156
-14,375
| -87% | -$793K | ﹤0.01% | 1111 |
|
|
2016
Q1 | $5.96M | Buy |
16,531
+7,255
| +78% | +$2.62M | 0.08% | 288 |
|
|
2015
Q4 | $5.04M | Sell |
9,276
-112
| -1% | -$60.8K | 0.07% | 328 |
|
|
2015
Q3 | $4.37M | Sell |
9,388
-450
| -5% | -$209K | 0.07% | 326 |
|
|
2015
Q2 | $5.02M | Sell |
9,838
-498
| -5% | -$254K | 0.08% | 319 |
|
|
2015
Q1 | $4.67M | Sell |
10,336
-42
| -0.4% | -$19K | 0.07% | 320 |
|
|
2014
Q4 | $4.26M | Sell |
10,378
-91
| -0.9% | -$37.4K | 0.06% | 329 |
|
|
2014
Q3 | $3.78M | Buy |
10,469
+325
| +3% | +$117K | 0.06% | 336 |
|
|
2014
Q2 | $2.86M | Buy |
10,144
+2,126
| +27% | +$600K | 0.05% | 368 |
|
|
2014
Q1 | $2.41M | Buy |
8,018
+113
| +1% | +$33.9K | 0.05% | 365 |
|
|
2013
Q4 | $2.18M | Buy |
+7,905
| New | +$2.18M | 0.06% | 330 |
|